Zomedica Corp. (ZOM) Stock on a Precipitous Rise, Here’s Why
Zomedica Corp. (ZOM), a veterinary health company, has surged 15.92% in aftermarket trading session. As a result, the stock is trading at $0.40 at the time of the writing. During Friday’s regular trading session, the stock declined by 3.32 percentage points and closed the day at $0.35. The stock is on the rise in the […]
Why Zomedica Corp. (ZOM) stock jumped on Thursday?
Zomedica Corp. (ZOM) shares were climbed 4.04% in after-hours on Thursday, June 17, 2021, and close the day at $0.94 per share. Earlier, ZOM’s stock gained 0.74% to close Thursday’s normal trading session at $0.90 per share. ZOM shares have risen 310.68% over the last 12 months, and they have moved down 3.81% in the […]
Zomedica Corp. (ZOM) stock plummeting continue since last week
Zomedica Corp. (ZOM) shares were falling -8.04% to trade at $1.03 in Tuesday’s premarket at last check. ZOM’s stock lost -9.68% to close Monday’s session at $1.12. ZOM shares have gained 729.63% over the last 12 months, and they have moved down by -15.79% in the past week. Over the past three months, the stock […]
So, this update pushing Zomedica Corp. (NYSE American: ZOM) stock up in the morning session
Zomedica Corp. (NYSE American: ZOM) stock was up trending higher than 12.8% to $1.1000 in the early morning trading session as it released the letter from Robert Cohen, Chief Executive Officer, to brief the shareholders of Zomedica on a range of critical operations and events: Get the hottest stocks to trade every day before the […]
Is Zomedica Corp. (ZOM) a Buy with the Recent Dip?
Zomedica is ready to initiate a new diagnostic platform that has backed its share price in recent times. But, what’s with this recent drop in ZOM? Zomedica Corp. (ZOM) has been updating regarding the highly anticipated launch of TRUFORMA. The company has completed its launch team and is set to commercialize its first product for […]
Zomedica Corp. (ZOM) stock plunged -8.56% to 0.1859 in the After-hours on Friday
However, the company announced mid-last-week that while the special virtual-only meeting of shareholders where a majority voted in favor of the company’s domestication to Delaware, shareholders failed to complete a 2/3 vote in favor of it, and the localization will therefore not happen. Covered by approximately 70 granted and pending patents, the TRUFORMA diagnostic platform […]
